Compare GT Protocol (GTAI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GT Protocol vs Enzyme — how do they compare? GT Protocol trades at Rp134.16 (market cap Rp10,04M, Rp3,04M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 13.4× GT Protocol's market cap, and GT Protocol's supply is capped (68,8M / 75M GTAI (92%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold GT Protocol for 18 Days and Enzyme for 29 Days on average.
| GTAI | MLN | |
|---|---|---|
Market Cap | Rp10,04M | Rp134,13M |
Volume (24h) | Rp3,04M | Rp104,56M |
Circulating Supply | 68,8M / 75M GTAI (92%) | 3,3M MLN |
Typical Hold Time | 18 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GT Protocol (GTAI) shows limited market activity with a modest market cap of Rp10.04M and 92% of tokens in circulation. The asset demonstrates minimal trading volume and liquidity, with a short average hold time of 18 days suggesting speculative trading patterns. No recent protocol updates or significant ecosystem developments were identified during the analysis period.
Overall outlook remains cautious due to low liquidity and limited market presence. Key opportunities include potential protocol development and ecosystem expansion, while major risks include high volatility, regulatory uncertainty, and low trading volume that could impact price stability.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About GT Protocol
The GT Protocol features a strong ecosystem that combines an investment protocol for decentralized Web3 fund management with Blockchain AI Execution Technology, all accessible through the GT API SDK. This ecosystem includes the GT APP, a Web3 investment platform that has already gained 70,000 registered users. It has achieved significant milestones, such as becoming an official broker for the Binance exchange and establishing a partnership with the TRON blockchain.
Read more on GTAI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
